Six Research Teams Receive Intermountain-Stanford Grant Award

The collaborative grants provide seed funding for projects aimed at transforming healthcare in multiple fields of medicine

SALT LAKE CITY, UTAH, USA, August 18, 2017 /EINPresswire.com/ — Stanford Medicine and Intermountain Healthcare have announced the recipients of more than $400,000 in seed grants focused on transforming healthcare.

The six projects were chosen from a competitive field of 23 proposals, using a vetting process similar to that used by the National Institutes of Health, which establishes selection criteria and scoring systems.

“The Intermountain-Stanford grant program is part of an exciting collaboration focused on advancing clinical care best practices, education and training, and clinical research in heart disease, cancer, and other conditions. This is the second year of the grant program, in September 2016 seven grants were awarded and those projects are underway. The purpose of the grant award is to spearhead and accelerate research between the two organizations and support innovative projects in research, patient care, and medical education” says Robert W. Allen, Intermountain Healthcare’s Senior Vice President and Chief Operating Officer.

“Our collaboration will foster those scientific discoveries that have potential to improve patient care in both institutions,” says David Larson, MD, MBA, co-chair of the Intermountain-Stanford Collaborative Committee and Stanford University School of Medicine’s Associate Professor of Pediatric Radiology and Associate Chair of Performance Improvement in the Department of Radiology.

The seed grants, up to $75,000 each, were awarded to projects that will be jointly led by principal investigators from Intermountain and Stanford, and will take effect on September 1, 2017.

The six selected projects focus on surgical health services, emergency medicine and electronic decision support, pediatric bronchiolitis, neonatal onset of sepsis, team-based primary care, and infectious disease. Although they’re from diverse clinical areas, all the studies are designed to improve patient care.

The six selected projects:

• Setting a foundation for collaborative surgical health services research at Stanford Health Care, Intermountain Healthcare, and the Veterans Health Administration — Stephen Warner, MD, Orthopedic Surgery, Intermountain Healthcare; Alex Sox-Harris, PhD, MS, Associate Professor (Research) of Surgery, Stanford.

• ePE: Electronic decision support for the diagnosis and treatment of acute pulmonary embolism in the emergency department — Joseph Bledsoe, MD, FACEP, Medical Director Emergency Medicine/Trauma, Intermountain Healthcare; Ian Brown, MD, MS, FAAEM, FACEP, Clinical Assistant Professor, Emergency Medicine, Stanford.

• Optimizing value in bronchiolitis: the bronchiolitis follow-up intervention trial (BeneFIT) — Eric Coon, MD, MS, Pediatric Medicine, Intermountain Primary Children’s Hospital; Alan Schroeder, MD, Associate Chief for Research in the Division of Pediatric Hospital Medicine at Lucile Packard Children’s Hospital Stanford.

• Early detection of neonatal early onset sepsis using the sepsis MetaScore: A genomic analysis of cord blood — Patrick Carroll, MD, MPH, Neonatology, Intermountain Healthcare; Purvesh Khatri, PhD, Assistant Professor (Research) of Medicine (Biomedical Informatics Research-ITI Institute) and of Biomedical Data Science, Stanford.

• Pragmatic Design for Enhanced Team-Based Primary Care — Brenda Reiss-Brennan, PhD, APRN, Behavioral Health Services Director, Intermountain Healthcare; Marcy Winget, PhD, Director, Evaluation Sciences Unit and Clinical Associate Professor in the Division of Primary Care and Population Health, Stanford School of Medicine.

• Repurposing an old drug for a new epidemic: ursodeoxycholic acid and clostridium difficile Infection — Brandon Webb, MD, Infectious Diseases, Intermountain Healthcare; Aruna Subramanian, MD, Clinical Associate Professor, Medicine – Infectious Diseases, Stanford.

“We are privileged to collaborate with the Stanford University School of Medicine, a premier medical school and worldwide leader in science and research,” says Raj Srivastava, MD, MPH, co-chair of the Intermountain-Stanford Collaborative Committee and AVP of Research at Intermountain Healthcare. “We are excited to launch these projects, foster new scientific collaborations focused on improving patient care, and set the stage for the healthcare transformation potential from the Intermountain-Stanford grant program.”

Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, 180 clinics, a Medical Group with some 1,500 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org,

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Brontosaurus Brought Back From Extinction

EverythingTiny has created three new Tinysaur kits of Brontosaurus, Quetzalcoatlus, and Fiji Mermaid. http://kck.st/2vARz5h

NEW YORK, NY, UNITED STATES, August 18, 2017 /EINPresswire.com/ — Tiny laser-cut skeleton models resemble giants at natural history museums. Designer Herb Hoover has created three new miniature bone kits for you to assemble.

BRONTOSAURUS REVIVAL
The once-stately brontosaurus had been removed from the cladogram because of a mistake by O.C. Marsh during the Dinosaur Wars in 1879. Debunked as only an apatosaurus, which was also discovered by Marsh, the brontosaurus went from being one of the best known dinosaurs to one of paleontology's best known blunders. However, in 2015, after a closer examination of Marsh's apatosaurus and brontosaurus fossils, scientists found significant enough differences to restore the bronto's good name.

PTINY PTEROSAUR
The Quetzalcoatlus is larger than a giraffe and scientists believe it could fly over 10,000 miles without stopping. In 2016, ornithologists observed birds sleeping in flight, so paleontologists have extrapolated the pterosaur's ability to sleep while in flight. Imagine if your captain did that.

MONKEY FISH
EverythingTiny's Fiji Mermaid is one of the designer's personal favorites. It's a mythical creature that conjured images of adventure and discovery on the high seas. The Zwaanendael Museum in Lewes Delaware has an exhibit of the taxidermied creature. Only a few specimens exist.

Tinysaurs are skeleton kits that you assemble into a miniature museum specimen. Bare bones kits come with tiny laser cut bones and printed instructions. All-in-one kits include laser-cut bones, printed instructions, a glass display dome with wooden base, tweezers, glue, and a magnifier — everything needed to build the tiny skeleton. EverythingTiny.com also hosts 3D instructions that you can rotate and zoom in on.

EverythingTiny's crowdfunding campaign will close on September 19th at 11 PM. They are currently ramping up production to create the parts and assemble them into the kits to ensure on-time delivery of the Kickstarter rewards.

Tinysaurs and Everythingtiny.com have been around since 2008 when Kelly Maguire fired a laser beam to create the first T-rex with a tripodal posture imitating a kangaroo. Herb Hoover has added 15 skeleton models and two add-on kits to the Tinysaur collection since their first Kickstarter campaign in 2013.

Herbert Hoover
EverythingTiny
2122804104
email us here


Source: EIN Presswire

Acute Myeloid Leukemia Treatment Market is projected to be worth $ 1.2 billion in 2023

Global Acute Myeloid Leukemia Treatment Market Information; by Disease Type (Myeloblastic, Promyeloctic, Myelomonocytic) by Treatment – Forecast to 2023

Major Key Players are Vaso Medical (USA), Tensys Medical Inc. (Netherlands), OrSense Ltd. (Israel),NIMD (Israel), Glucowise (UK), CNSystems Medizintechnik AG (Austria), ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, August 18, 2017 /EINPresswire.com/ — Market Research Future Publish a New Report on – “Acute Myeloid Leukemia Treatment Market Research Report- Global Forecast to 2023”

Executive Summery
Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.

Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.3 % during 2017-2023.

Acute Myeloid Leukemia Treatment Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Vaso Medical (USA),
• Tensys Medical Inc. (Netherlands),
• OrSense Ltd. (Israel),
• NIMD (Israel),
• Glucowise (UK),
• CNSystems Medizintechnik AG (Austria),
• RSP systems A/S (Denmark)
• GE Healthcare (UK),
• Siemens (Germany),
• Abbott (USA),
• Nemaura (UK)
• Integrity (Israel).

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3223

Intended Audience
• Global acute myeloid leukemia treatment solutions providers.
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities

Segments:
The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission.

Taste the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Acute Myeloid Leukemia Treatment Market Research Report

Regional analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

The report for Global Acute myeloid leukemia treatment Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223

Table of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Acute Myeloid Leukemia Treatment Market, By Disease Type
5.1 Myeloblastic
5.2 Promyeloctic
5.3 Myelomonocytic
5.4 Monocytic
5.5 Erythroleukemia
5.6 Megakaryocytic
6 Global Acute Myeloid Leukemia Treatment Market, By By Treatment
6.1 Chemotherapy
6.1.1 Induction
6.1.2 Post Remission
6.2 Hematopoietic Stem Cell Transplantation
7. Global Acute Myeloid Leukemia Treatment Market, By Region
Continued…..

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Percutaneous Coronary Intervention Market is projected To Grow At A CAGR Of 10.8% by 2023

Percutaneous Coronary Intervention Market Info by Stents (Drug-eluting Stents (DES), Bare Metal Stents, Bioresorbable Stents)by Surgery Type – Forecast to 2023

Major Key Players are Abbott Vascular, Svelte Medical, Medtronic Plc., Boston Scientific, Sysmetis, Cardiac Dimensions, Acrostak, Edwards Lifesciences ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, August 18, 2017 /EINPresswire.com/ — Market Research Future Publish a New Report on – “Global Percutaneous Coronary Intervention Market Research Report – Forecast To 2023”

Executive Summery
Percutaneous Coronary Intervention (PCI) is a non-surgical procedure used to treat narrowing of the coronary arteries of the heart by placing a stent in the contracting artery. PCI uses imaging techniques to guide the stent to the exact location.

The market for PCI is increasing due to rise in risk factors associated with heart diseases such as obesity, smoking and substance abuse, fatty foods etc. The life threatening nature of coronary heart diseases, greater reimbursement to heart diseases, the growth of specialty hospitals etc. are driving the market for PCI. The most critical technological growth factor however is the development of advanced stents such as drug-eluting stents (DES), bare metal stents, bioresorbable stents and the falling cost of these stents.
The regulatory changes in the U.S. is affecting the PCI market positively. For example, the FDI changed the class of standard balloon-tipped angioplasty catheters from Class III medical devices to Class II devices with special controls. Thus companies can now avoid pre-market approval (PMA) process to bring their device to the market. Thus companies will achieve faster clearance for their devices with added advantage of less cost.

The market constraints are the high cost of the procedure, coupled with the risks involved, the low availability of cardiac surgeons, low number of cardiac hospitals etc.

Considering all these factors the market for percutaneous coronary intervention is expected to reach $ 15,769 million by the end of 2023, this market is projected to growing at a CAGR of ~10.8% during 2017-2023.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3166

Percutaneous Coronary Intervention Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Major Key Players

• Abbott Vascular,
• Svelte Medical,
• Medtronic Plc.,
• Boston Scientific,
• Sysmetis,
• Cardiac Dimensions,
• Acrostak,
• Edwards Lifesciences

Intended Audience
• Global Percutaneous coronary intervention solutions providers, manufacturers & suppliers
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Percutaneous coronary intervention Market” Research Report – Forecast to 2023.”

Segments:
The Global percutaneous coronary intervention market is segmented on the basis of stents. Based on the stents, the market has been segmented as drug-eluting stents (DES), bare metal stents and bioresorbable stents. The surgery type segment is further sub segmented into percutaneous coronary intervention (PCI), transcatheter aortic valve implantation (TAVI/TAVR), trans-mitral valve implantation (TMVR). Similarly the cosmetic implants segment is sub segmented into breast augmentation, buttock implants, chin & cheek implants.

Regional analysis
US accounts for the maximum market share of the global percutaneous coronary intervention market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of awareness and the growing acceptability of percutaneous coronary intervention. Advancing technologies within the percutaneous coronary intervention such as advanced silicone and polymer implants is also driving the market. However there is a definite shift of percutaneous coronary intervention market to Asia pacific and Latin America with the most active part played by medical tourism industry.

The report for Global Percutaneous coronary intervention Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @ https://www.marketresearchfuture.com/reports/percutaneous-coronary-intervention-market-3166

Table of Content
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
——-
9 Company Profile
9.1 Abbott Vascular
9.1.1 Overview
9.1.2 Product Overview
9.1.3 Financials
9.1.4 Key Developments
9.2 Svelte Medical
9.2.1 Overview
9.2.2 Product Overview
9.2.3 Financials
9.2.4 Key Developments
9.3 Medtronic Plc.
Continued…..

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Migraine Therapeutics Development and Professional Review Analysis 2017

Migraine Pharmaceutical and Healthcare Review

PUNE, INDIA, August 18, 2017 /EINPresswire.com/ — Pune, India, 18th August 2017: WiseGuyReports announced addition of new report, titled “Global Migraine Market Report: 2016 Edition”.

Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to result from the activation and sensitization of sensory neurons that have nerve endings in meningeal blood vessels. Migraines can be episodic or chronic. Chronic Migraine (CM) and Episodic Migraine (EM) are both part of the spectrum of migraine disorders, but are distinct clinical entities. The onset of migraine is preceded by certain triggers, which can be unique for each migraine sufferer.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1615780-global-migraine-market-report-2016-edition

Triptans and Ergots are among the most common drug options existing in the treatment market for migraine. The global migraine treatment market currently faces several unmet needs and is saturated with the availability of generic drugs. Several branded drugs are under development with safer and more effective profiles, given the vast opportunities existing in the market. The focus of upcoming drugs is to either cure migraine or to reduce the frequency to a level where patients can find tolerable relief.

The migraine market is expected to acquire modest growth driven by launch of new therapies and increasing rate of drug treatment due to increasing female population and rising awareness among physicians and patients. The major growth drivers of the migraine market includes rising spending on medicines, growing female population, increasing cigarette consumption and healthcare expenditure. However, the growth of the market will also remain challenged by complications associated with Triptans, treatment limitations for patients with CV (Cardio Vascular) risk and increased preference for OTC (Over the Counter) medications.

The report, “Global Migraine Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific market of the U.S. is being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

Table of Content: Key Points

1. Market Overview
1.1 Introduction
1.2 Types
1.3 Causes and Pathogenesis
1.4 Symptoms and Diagnosis
1.5 Treatment Options

2. Global Migraine Market
2.1 Global Migraine Drug Market by Value
2.2 Global Migraine Drug Market by Category
2.3 Global Therapeutic Botulinum Toxin Market by Value
2.4 Global Therapeutic Botulinum Toxin Market by Indication

3. The U.S. Migraine Market
3.1 The U.S. Total Migraine Population
3.2 The U.S. Migraine Population by Diagnosis
3.3 The U.S. Migraine Population with CV Risk Factors
3.4 The U.S Preventive Migraine Treatment by Specialty
3.5 The U.S. Acute Migraine Treated Population by Drug Type
3.6 The U.S. Acute Migraine Prescription Volume
3.7 The U.S. Migraine Drugs Revenue
3.7.1 Cambia
3.7.2 Lasmiditan

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Spending on Medicines
4.1.2 Growing Female Population
4.1.3 Increasing Cigarette Consumption
4.1.4 Rising Healthcare Expenditure

4.2 Trends
4.2.1 Emergence of Peripheral Nerve Stimulators
4.2.2 Increased Preference for Non Pharmacological Treatment
4.2.3 Higher Prevalence of Migraine than Other Chronic Diseases
4.2.4 Recurrent Symptoms in Migraine Patients
4.2.5 Drugs under Development for Migraine

4.3 Challenges
4.3.1 Complications associated with Triptans
4.3.2 Treatment Limitations for Patients with Cardiovascular Disease
4.3.3 Rise in Prescription Drugs to OTC Switch

5. Competitive Landscape
6. Company Profiles
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1615780-global-migraine-market-report-2016-edition

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Anti-Nuclear Antibody (ANA) Testing Market shows an impressive growth to reach US$ 1300.6 million by 2023

Anti-nuclear Antibody (ANA) Testing Market information, by type (immunofluorescence, enzymelinked, immunosorbent ),by application,by End User – Forecast to 2023

Major Key Players are Abcam plc. (US), Alere (US), Antibodies Inc.(US), Bio-Rad Laboratories, Inc. (US), Erba Diagnostics (US), Indur Services, Inc. (US), ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, August 18, 2017 /EINPresswire.com/ — Market Research Future Publish a New Report on – “Global Anti-nuclear Antibody (ANA) Testing Market – Forecast To 2023”

Executive Summery
Anti-nuclear Antibody (ANA) Test is used to detect antinuclear antibodies in blood. Immune system makes antibodies to fight with various infections. Antinuclear antibodies often attack on own tissues. ANA test helps to determine autoimmune diseases like rheumatoid arthritis and lupus. Increasing technological advancements, adoption of new techniques and increasing prevalence of various autoimmune diseases are driving the growth for global anti-nuclear antibody (ANA) testing market. Major brands are investing money in R&D to develop more advanced product for the market that is another key driver for the market.

The Global Anti-nuclear Antibody (ANA) testing market is growing at the CAGR of ~9.6% during the forecast period and expected to reach US$ 1300.6 million by 2023.

Anti-nuclear Antibody (ANA) Testing Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Abcam plc. (US),
• Alere (US),
• Antibodies Inc.(US),
• Bio-Rad Laboratories, Inc. (US),
• Erba Diagnostics (US),
• Indur Services, Inc. (US),
• MBL INTERNATIONAL (US),
• Merck KGaA (Germany),
• Trinity Biotech (Republic of Ireland)

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3210

Intended Audience
• Anti-nuclear Antibody (ANA) Test products manufacturers
• Anti-nuclear Antibody (ANA) Test products and services providers
• Medical Research laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors

Segments:
Global Anti-nuclear Antibody (ANA) Testing Market has been segmented on the basis of type which comprise immunofluorescence (Primary or direct and Secondary or indirect), enzymelinked, immunosorbent assay (ELISA) (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competition/Inhibition ELISA), and others. On the basis of application, it segmented into Rheumatoid arthritis (Seropositive, Seronegative), Systemic lupus erythematosus (SLE) (Discoid lupus erythematosus, Subacute cutaneous lupus erythematosus, Neonatal lupus), Polymyositis, Scleroderma (localized scleroderma, systemic scleroderma), Sjögren's syndrome (Primary, secondary) , and others. On the basis of end user, it segmented into Hospitals and clinics, research laboratories, and others.

Taste the market data and market information presented through more than 56 market data tables and figures spread over 72 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Anti-nuclear Antibody (ANA) Testing Market Research Report –Global Forecast to 2023.”

Regional Analysis of Global Anti-nuclear Antibody (ANA) Testing Market:
Considering the global scenario of the market, North America is largest market for Anti-nuclear Antibody (ANA) Testing, in North America region US hold largest market share while European market is second largest, and especially the growth rate is higher in west European countries. On the other hand, Asia-Pacific (APAC) is fastest growing market and expected to grow significantly during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of devices and treatment.

The report for Global Anti-nuclear Antibody (ANA) Testing Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry
performance.

If you have any special requirements, please let us know and we will offer you the report as you want.

For further information on this report, visit @ https://www.marketresearchfuture.com/reports/anti-nuclear-antibody-testing-market-3210

Table of Content

1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Upcoming trends
5.7.1 Market trends
5.7.2 Technological trends
5.7.3 Insurance & Regulations
5.7.4 Others
6. Global Anti-nuclear Antibody (ANA) Testing Market by Type
Continued…..

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Alginates Market Predicted to Observe a Steady Growth by 2027

MRFR Banner

Market Research Future

Alginates Market Research – by Species Type (Laminaria), Function (Thickeners, Emulsifiers), Application (Biofuels) and Region- Forecast to 2027

Major Key Players are CP Kelco, Ingredients Solutions Inc., Cargill Foods, P.L. Thomas & Co., TIC Gums, Linyi Viho Chem Co., Ltd., Foodchem International Corporation, Qingdao Tocean Chemical Co.”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, August 18, 2017 /EINPresswire.com/ — Market – Overview:

Alginates are a group of viscous polysaccharides derived from brown seaweeds and produced as an extracellular matrix by some bacterial species. Traditionally, Alginates have been used as thickeners, emulsifiers and stabilising agents in a number of food applications. A number of new food applications are emerging for Alginates, based on their unique biochemical and biophysical properties.

Alginates are a biomaterial that has found numerous applications in biomedical science and engineering due to its favourable properties, including biocompatibility and ease of gelation. Alginates hydrogels have been particularly attractive in wound healing, drug delivery, and tissue engineering applications to date, as these gels retain structural similarity to the extracellular matrices in tissues and can be manipulated to play several critical roles.
Over the last decades, Alginates, natural multifunctional polymers, have increasingly drawn attention as attractive compounds in the biomedical and pharmaceutical fields due to their unique physicochemical properties and versatile biological activities.

Western countries particularly the U.S., Canada, Mexico and Germany France have higher demand for Alginates. Rise in downstream market applications for Alginates from food and beverages, pharmaceuticals and other industrial applications are driving higher demand for Alginates.

Alginates is gaining a huge traction especially from food and beverages industry in the current time, owing to its functional properties such as thickening agent, gelling agent, stabilizer, emulsifier and film-forming property. This increasing demand in food industry is attributed due to its extraction from natural seaweeds is it considered as one of safest food additive in food industry it is also certified by FAO/WHO. Simultaneously, Demand for Alginates from textile industry is also on rise as it can be used for printing, designing and dyeing on cotton and jute fabrics.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1581

Key Players:

CP Kelco, Ingredients Solutions Inc., Cargill Foods, P.L. Thomas & Co., TIC Gums, Linyi Viho Chem Co., Ltd., Foodchem International Corporation, Qingdao Tocean Chemical Co., Ltd, and Kimica are some of the key players at the forefront of competition in the Global Alginates Market and profiled in MRFR Analysis.

Competitive Analysis:

The Alginates market appears to be highly competitive and fragmented owing to the presence of several large and small key players accounting for a substantial market share. These key players compete based on pricing, and product innovation. Well established players incorporate acquisition, collaboration, partnership, expansion, and product in order to gain competitive advantage in this market and to maintain their market position. Manufacturers are striving to find ways to reduce raw material prices. Raw material suppliers apply the power to determine prices of raw materials, which has an impact on the business.

Access the market data and market information presented through more than 60 market data tables and 25 figures spread over 115 numbers of pages of the project report “Alginates Market – Forecast to 2027”

Market – Segments:

The Alginates Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

• Segmentation On the basis of Type: Comprises Laminaria, Macrocystis, Ascophyllum, Lessonia, Durvillaea, Ecklonia and others.
• Segmentation On the basis of Functions: Comprises Thickeners, Emulsifiers, Stabilizers, Acidity Regulators and others.
• Segmentation On the basis of Application: Comprises Food and Beverages, Biofuels, Textile Industry, Paper and Pulp, Pharmaceuticals and others.
• Segmentation On the basis of Regions: Comprises Geographical regions – North America, Europe, APAC and Rest of the World.

Market – Synopsis:

Alginate is used for substrate of colour paste when applying patterns to print fabrics, scarf, towel, etc. Use of alginate for printing of cotton, jute, rayon is mandatory. Alginate, a seaweed extract, is safer and easier to be decomposed compared with other substrate for textile printing, and gives easier waste water disposal. Alginate is used for the production of welding rod, as a binder of flux. Alginate is used as a binder and thickening agent for pet-food, fish feed, etc.

Access Report Details @ https://www.marketresearchfuture.com/reports/alginates-market-1581

Regional Analysis:

• North-America dominated the market for Alginates in terms of demand with the largest market share, accounting for astronomical amounts and is expected to grow further over its previous growth records by 2027; Asia-Pacific is the growing market for Alginates market and is expected to grow at a substantial CAGR from 2016 to 2027.
• Europe and Asia Pacific regions being the largest producers of Alginates contribute majority of market share in global level market. In terms of value, it is expected that Europe and North America accounted for a major share in terms of value and also as a lucrative market in near future.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Akash Anand
Market Research Future
+1-646-845-9349 (US) / +44 208 133 9349 (UK)
email us here


Source: EIN Presswire

Global Cancer Biomarkers Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Wiseguyreports.Com Adds “Cancer Biomarkers Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”

PUNE, INDIA, August 18, 2017 /EINPresswire.com/ —

Summary

This report studies the global Cancer Biomarkers market, analyzes and researches the Cancer Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Illumina, Inc.
Agilent Technologies
QIAGEN
Merck & Co., Inc.
Hologic, Inc.
Novartis AG
bioMérieux SA
Genomic Health, Inc.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1757902-global-cancer-biomarkers-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Cancer Biomarkers can be split into
PSA Tests
CTC Tests
AFP Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others

Market segment by Application, Cancer Biomarkers can be split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others

At any Query @ https://www.wiseguyreports.com/enquiry/1757902-global-cancer-biomarkers-market-size-status-and-forecast-2022

Table of Contents

Global Cancer Biomarkers Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Biomarkers
1.1 Cancer Biomarkers Market Overview
1.1.1 Cancer Biomarkers Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Biomarkers Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Biomarkers Market by Type
1.3.1 PSA Tests
1.3.2 CTC Tests
1.3.3 AFP Tests
1.3.4 HER2 Tests
1.3.5 BRCA Tests
1.3.6 ALK Tests
1.3.7 CEA Tests
1.3.8 EGFR Mutation Tests
1.3.9 KRAS Mutation Tests
1.3.10 Others
1.4 Cancer Biomarkers Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Lung Cancer
1.4.3 Colorectal Cancer
1.4.4 Melanoma
1.4.5 Blood Cancer
1.4.6 Prostate Cancer
1.4.7 Ovarian Cancer
1.4.8 Stomach Cancer
1.4.9 Liver Cancer
1.4.10 Others

2 Global Cancer Biomarkers Competition Analysis by Players
2.1 Cancer Biomarkers Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Thermo Fisher Scientific Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Illumina, Inc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Agilent Technologies
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 QIAGEN
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Merck & Co., Inc.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Hologic, Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Novartis AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 bioMérieux SA
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Genomic Health, Inc.

4 Global Cancer Biomarkers Market Size by Type and Application (2012-2017)
4.1 Global Cancer Biomarkers Market Size by Type (2012-2017)
4.2 Global Cancer Biomarkers Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Biomarkers in Future
4.4 Top Consumer/End Users of Cancer Biomarkers

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1757902

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Growth Hormone Deficiency Market 2017 -Develop Market-Entry and Market Expansion Strategies 2026

Growth Hormone Deficiency Market

PUNE, MAHARASHTRA, INDIA, August 18, 2017 /EINPresswire.com/ —

SUMMARY

WiseGuyReports published new report, titled “OpportunityAnalyzer: Growth Hormone Deficiency – Opportunity Analysis and Forecasts”.

Growth hormone deficiency (GHD) is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH) from the anterior pituitary gland. It is a heterogeneous disorder that may present in childhood (pediatric GHD) or later in adult life (adult GHD). Reduced GH secretion predominantly results in stunted linear growth in children; therefore, the standard-of-care GH replacement therapy serves to normalize height in children. Adults with GHD generally demonstrate biochemical abnormalities, which can also be successfully treated with recombinant GH. estimates the 2016 sales for GHD at approximately $1.42 billion across the 7MM covered in this report. The market will grow moderately at a CAGR of 3.9% during the 10-year forecast period, generating sales of approximately $2.08 billion at the end of 2026. The US market is expected to grow the fastest of the three regions, recording a CAGR of 4.4% and generating around 69% of global sales in 2026. This growth will be driven primarily by the highly anticipated arrivals of the long-acting GHs and the resultant increase in compliance with and adherence to therapy. Although the more convenient long-acting GHs are expected to markedly change the GHD treatment landscape, and eventually replace daily GHs, market growth will be restricted by the continued negotiations between distributers and payers, which is expected to keep the prices of these new drugs at bay.

Key Questions Answered

– Overall, the greatest unmet need in the GHD space is the issue with treatment adherence and compliance. There are other prominent unmet needs highlighted by the Key Opinion Leaders (KOLs). What are these? Will the pipeline drugs fulfil these unmet needs of the market?
– The 10-year forecast period will mark the launch of four pipeline long-acting GH drugs. How will the sales of the existing drugs be impacted? Which of the pipeline drugs will have the highest peak sales at the highest CAGR, and why?
– What are the roles of payers in this highly competitive disease space? How does this affect market shares of the GH brands? What are the chances of reimbursement for the long-acting GH drugs in pipeline?

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1793407-opportunityanalyzer-growth-hormone-deficiency-opportunity-analysis-and-forecasts-to-2026

Scope

– Overview of GHD, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
– Annualized GHD therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2016 and forecast for ten years to 2026.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the GHD therapeutics market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
– Analysis of the current and future market competition in the global GHD therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Key points to buy

The report will enable you to –

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
– Develop business strategies by understanding the trends shaping and driving the global GHD therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global GHD therapeutics market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track drug sales in the 7MM GHD therapeutics market from 2016-2026.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

1 Table of Contents
2 Growth Hormone Deficiency: Executive Summary
3 Introduction
4 Disease Overview
5 Epidemiology
6 Current Treatment Options
7 Unmet Needs and Opportunity Assessment
8 R&D Strategies
9 Pipeline Assessment
10 Pipeline Valuation Analysis
11 Appendix

..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check

https://www.wiseguyreports.com/seminars

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Time Scarcity Market 2017–By Identifying the Key Market Segments and Key players holding market share

Time Scarcity – Opportunities and Analysis of Top Key Player Forecast

PUNE, INDIA, August 18, 2017 /EINPresswire.com/ — Pune, India, 18thAugust 2017: WiseGuyReports announced addition of new report, titled “TrendSights Analysis: Time Scarcity”.

Summary
"TrendSights Analysis: Time Scarcity" looks at meeting demand for convenient, time-saving products and services.
Demand for ease and convenience derives from being time-poor and a perception of not having enough time to do all the things that one wants or needs to do. Convenience needs pervade all aspects of life, forcing dependence on highly efficient and effective products that better facilitate busy lifestyles and maximize leisure time.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1119645-trendsights-analysis-time-scarcity

Scope
– Age of connectivity has fueled an "always on" mode among consumers seeking instant gratification from the products and services they use.
– Millennials heavily rely on time-saving products, and are most likely to work long hours and/or have a long commute compared to other cohorts.
– Fortification provides a "quick fix" way to boost nutrient levels, with 49% of consumers agreeing that food and drink is the most effective format for delivering health-enhancing ingredients.

Reasons to buy
– Gain insight into the different routes through which products can align with consumers' time scarcity – formulation, packaging,, and formats.
– Compare the presence of this trend in each industry across the FMCG space, and learn what the key opportunities are.
– Identify the innovation implications of Time Scarcity for your sector

Table of Content: Key Points
1 Trend Snapshot 6
2. What is Time Scarcity? 9
3. Why is Time Scarcity important? 18
4. Who is driving Time Scarcity? 20
5. How can Time Scarcity be capitalized on? 21
6. What Next in Time Scarcity? 28
7. Appendix 30
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1119645-trendsights-analysis-time-scarcity

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire